相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial
Abid Ullah et al.
ANTIBIOTICS-BASEL (2022)
Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis
Einat Gorelik et al.
DRUG SAFETY (2019)
Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review
Fahadullah Khan et al.
EXPERT OPINION ON DRUG SAFETY (2018)
QT Prolongation and Malignant Arrhythmia: How Serious a Problem?
Christos-Konstantinos Antoniou et al.
EUROPEAN CARDIOLOGY REVIEW (2017)
Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach
Gopi Krishna Panicker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study
Joel Morganroth et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Dysglycemia associated with quinolones
Sarah El Ghandour et al.
PRIMARY CARE DIABETES (2015)
The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects
Seol Ju Moon et al.
DRUGS IN R&D (2014)
Risk of Severe Dysglycemia Among Diabetic Patients Receiving Levofloxacin, Ciprofloxacin, or Moxifloxacin in Taiwan
Hsu-Wen Chou et al.
CLINICAL INFECTIOUS DISEASES (2013)
Ciprofloxacin and the risk for cardiac arrhythmias: culprit delicti or watching bystander?
Bernhard Haring et al.
ACTA CARDIOLOGICA (2012)
Biology of cardiac sodium channel Na(v)1.5 expression
Martin B. Rook et al.
CARDIOVASCULAR RESEARCH (2012)
Life-Threatening Hypoglycemia With Moxifloxacin in a Dialysis Patient
Rajan Kapoor et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications
Alexandros Briasoulis et al.
CARDIOLOGY (2011)
Drug- and non-drug-associated QT interval prolongation
Charlotte van Noord et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Safety Profile of the Fluoroquinolones Focus on Levofloxacin
Hans H. Liu
DRUG SAFETY (2010)
Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death
Rainer Surges et al.
EPILEPSIA (2010)
Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation Endorsed by the American Association of Critical-Care Nurses and the International Society for Computerized Electrocardiology
Barbara J. Drew et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mechanisms of Drug Induced QT Interval Prolongation
Marcelo Luis Ponte et al.
CURRENT DRUG SAFETY (2010)
Severe Dysglycemia with the Fluoroquinolones: A Class Effect?
Sherrie L. Aspinall et al.
CLINICAL INFECTIOUS DISEASES (2009)
Normal limits of the spatial QRS-T angle and ventricular gradient in 12-lead electrocardiograms of young adults: dependence on sex and heart rate
Roderick W. C. Scherptong et al.
JOURNAL OF ELECTROCARDIOLOGY (2008)
Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use E14 Guideline
B Darpo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
QT interval: How to measure it and what is normal
I Goldenberg et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2006)
Electrophysiological safety of novel fluoroquinolone antibiotic agents gemifloxacin and balofloxacin
Dong Seop Kim et al.
DRUG AND CHEMICAL TOXICOLOGY (2006)
Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: Nested case-control study
JF Graumlich et al.
PHARMACOTHERAPY (2005)
Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factors
K Amankwa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Clinical relevance and management of drug-related QT interval prolongation
MA Crouch et al.
PHARMACOTHERAPY (2003)
The quinolones: decades of development and use
AM Emmerson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates
A Speciale et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death
AH Glassman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG
JS Kang et al.
MOLECULAR PHARMACOLOGY (2001)
Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects
JL Démolis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
The fluoroquinolone antibacterials: past, present and future perspectives
PC Appelbaum et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
分享论文
